Interestingly, researchers found that genetically modified tumor cells with SLPI overexpressing did not exhibit tumorigenesis in immunocompetent mice and may act as a vaccine that partially restrains tumor growth and stimulate the adaptive immune response [63]. The gene discussed is SLPI; the disease is neoplasm.